Aisling Capital LLC - PERNIX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
Aisling Capital LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2016$1,246,000
+37.7%
2,010,0000.0%0.26%
+20.1%
Q2 2016$905,000
-57.1%
2,010,0000.0%0.21%
-49.4%
Q1 2016$2,111,000
-64.4%
2,010,0000.0%0.42%
-58.7%
Q4 2015$5,930,000
-6.6%
2,010,0000.0%1.02%
-8.4%
Q3 2015$6,352,000
-46.6%
2,010,0000.0%1.12%
-37.0%
Q2 2015$11,899,000
-44.6%
2,010,0000.0%1.77%
-37.0%
Q1 2015$21,487,000
+13.8%
2,010,0000.0%2.81%
-1.7%
Q4 2014$18,874,000
+22.2%
2,010,0000.0%2.86%
-4.4%
Q3 2014$15,440,000
-14.9%
2,010,000
-0.5%
2.99%
-42.9%
Q2 2014$18,140,0002,020,0005.24%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q4 2016.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders